Table 1.
Characteristics | ASC | AC | p value |
---|---|---|---|
Number | 93(0.2%) | 41794(99.8%) | |
Age (years) | 68.72±12.42 | 70.85±15.19 | 0.078 |
Gender | |||
Female | 35(37.6%) | 17194(41.1%) | 0.528 |
Male | 58(62.4%) | 24600(58.9%) | |
Ethnicity | |||
White | 56(60.2%) | 26146(62.6%) | 0.078 |
Black | 25(26.9%) | 7280(17.4%) | |
Other | 12(12.9%) | 8262(19.8%) | |
Unknown | 0 | 106(0.3%) | |
Marital status | |||
Single | 14(15.1%) | 5222(12.5%) | 0.128 |
Married | 58(62.4%) | 22164(53.0%) | |
Separated/divorced | 6(6.5%) | 3402(8.1%) | |
Widowed | 10(10.8%) | 8837(21.1%) | |
Other/unknown | 5(5.4%) | 2169(5.2%) | |
Primary site | |||
Fundus | 9(9.7%) | 2403(5.7%) | 0.155 |
Body | 8(8.6%) | 5244(12.5%) | |
Antrum | 26(28.0%) | 12233(29.3%) | |
Pylorus | 7(7.5%) | 1871(4.5%) | |
Lesser curvature, NOS | 14(15.1%) | 4884(11.7%) | |
Greater curvature, NOS | 4(4.3%) | 2197(5.3%) | |
Overlapping lesion | 13(14.0%) | 4304(10.3%) | |
Stomach, NOS | 12(12.9%) | 8658(20.7%) | |
Pathological differentiation | |||
Well | 1(1.1%) | 1924(4.6%) | 0.002 |
Moderate | 11(11.8%) | 11031(26.4%) | |
Poor | 69(74.2%) | 21885(52.4%) | |
Undifferentiated | 2(2.2%) | 637(1.5%) | |
Unknown | 10(10.8%) | 6317(15.1%) | |
Summary stage | |||
In situ | 0 | 555(1.3%) | 0.002 |
Localized | 9(9.7%) | 10009(23.9%) | |
Regional | 37(39.8%) | 12785(30.6%) | |
Distant | 43(46.2%) | 14026(33.6%) | |
Unstaged | 4(4.3%) | 4419(10.6%) | |
T stage | |||
T0/Tis/T1 | 7(7.5%) | 7740(18.5%) | 0.036 |
T2 | 19(20.4%) | 8132(19.5%) | |
T3 | 9(9.7%) | 3428(8.2%) | |
T4 | 14(15.1%) | 3762(9.0%) | |
Unknown | 44(47.3%) | 18732(44.8%) | |
Lymph node metastasis | |||
Yes | 32(34.4%) | 11747(28.1%) | 0.259 |
No | 23(24.7%) | 13233(31.7%) | |
Unknown | 38(40.9%) | 16814(40.2%) | |
Distant metastasis | |||
Yes | 31(33.3%) | 9970(23.9%) | 0.026 |
No | 28(30.1%) | 17871(42.8%) | |
Unknown | 34(36.6%) | 13953(33.4%) | |
Surgery | |||
Yes | 57(61.3%) | 21113(50.5%) | 0.080 |
No | 36(38.7%) | 20130(48.2%) | |
Unknown | 0 | 551(1.3%) | |
Radiation | |||
Yes | 19(20.4%) | 6880(16.5%) | 0.326 |
No/unknown | 74(79.6%) | 34914(83.5%) | |
Chemotherapy | |||
Yes | 41(44.1%) | 14218(34.0%) | 0.048 |
No/unknown | 52(55.9%) | 27576(66.0%) |
ASC: adenosquamous carcinoma; AC: adenocarcinoma. The significant p values are in bold.